R & d cell based wound therapeutics

Ended Definitive Contract Awarded Last action

Contract number
N6264518C4018
Awardee
Awarding agency
Obligated
$7,905,000

Award facts

Opportunity
Contract value 100% obligated
$7,905,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Cost No Fee
Place of performance
Pittsburgh, PA 15219, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 -$1,750,000
Other Administrative Action P00001 $0
Original award $9,655,000

About this award

This is a $7,905,000.00 cost-type definitive contract awarded by the Bureau of Medicine and Surgery (a component of the U.S. Department of Defense) to Noveome Biotherapeutics Inc. for the research and development of a cell-based wound therapy for the treatment of eye trauma resulting from combat injuries. The contract builds upon Noveome's prior preclinical and clinical work with amnion-derived stem cell secretome products, and includes manufacturing, clinical trial, and regulatory activities. This award was the result of a sources sought process and is not associated with a larger contract vehicle. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract N6264518C4018?

N6264518C4018 was awarded to Noveome Biotherapeutics Inc. by Bureau of Medicine and Surgery (Department of the Navy) on September 28, 2018.

How much is contract N6264518C4018 worth?

The government has obligated $7,905,000 on N6264518C4018.

Was contract N6264518C4018 competed?

The extent of competition for N6264518C4018 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award